Neuroprotective Effect of Simvastatin in Stroke: A Comparison Between Adult and Neonatal Rat Models of Cerebral Ischemia
- 31 May 2005
- journal article
- review article
- Published by Elsevier in NeuroToxicology
- Vol. 26 (5) , 929-933
- https://doi.org/10.1016/j.neuro.2005.03.009
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- New therapeutic strategies in perinatal stroke.Current Drug Targets-CNS & Neurological Disorders, 2004
- Mechanisms of stroke protection by physical activityAnnals of Neurology, 2003
- Prophylactic but Not Delayed Administration of Simvastatin Protects Against Long-Lasting Cognitive and Morphological Consequences of Neonatal Hypoxic-Ischemic Brain Injury, Reduces Interleukin-1β and Tumor Necrosis Factor-α mRNA Induction, and Does Not Affect Endothelial Nitric Oxide Synthase ExpressionStroke, 2003
- Simvastatin Protects Against Long-Lasting Behavioral and Morphological Consequences of Neonatal Hypoxic/Ischemic Brain InjuryStroke, 2001
- Mevastatin, an HMG-CoA Reductase Inhibitor, Reduces Stroke Damage and Upregulates Endothelial Nitric Oxide Synthase in MiceStroke, 2001
- Reduction of Stroke Events With PravastatinCirculation, 2001
- Long-lasting behavioral alterations following a hypoxic/ischemic brain injury in neonatal ratsBrain Research, 2000
- Pathobiology of ischaemic stroke: an integrated viewPublished by Elsevier ,1999
- Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthaseProceedings of the National Academy of Sciences, 1998
- Dual role of nitric oxide in focal cerebral ischemiaNeuropharmacology, 1994